Dr. William von Almen, M.D., FACOG is an experienced minimally invasive gynecologic surgeon who has been in private practice for 28 years.
Dr. William von Almen, M.D., FACOG is an experienced minimally invasive gynecologic surgeon who has been in private practice for 28 years. He currently operates at Crescent City Physicians in New Orleans, Louisiana. In these videos, he answers the most common questions his patients have when faced with a decision to have a hysterectomy. These videos are intended to complement the Questions to Ask your Doctor section of this site.
Dr. von Almen received financial support from Olympus Corporation for the clinical videos on this website.
Important Note to Reader: The information in these Web pages is for your general knowledge and background only. Note that these Web pages contain information from various sources considered to be dependable. However, we make no representations, warranties or other expressed or implied warranties or guarantees regarding the accuracy, reliability or completeness of the information. Under no circumstance shall Gyrus ACMI, Inc., Olympus America Inc. and/or its or their respective affiliates, employees, consultants, agents or representatives (collectively "Gyrus") be liable for any costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be in incurred in connection with the information provided or any use thereof.
© 2010 Gyrus ACMI, Inc. All rights reserved. | Privacy Policy | Legal Notice
Self-diagnosing vaginismus found accurate vs health care provider diagnosis
October 15th 2024In a recent study presented at the 25th Annual Fall Scientific Meeting of SMSNA, similar diagnosing success was reported between self-diagnosis and diagnosis from a health care provider for vaginismus.
Read More
CD outcomes similar between single- vs double-layer uterine closure
September 24th 2024In a recent study, similar rates of live birth and other pregnancy outcomes were reported between patients receiving double- vs single-layer uterine closure following cesarean delivery, indicating a lack of superiority from a single method.
Read More
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More